Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Recipharm Stockholm AB
AB
In liquidation
Org 5566668249
Stockholm
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2004
0 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Recipharm Stockholm AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
5M
11M
16M
22M
19M
2021
0M
2022
0M
2023
-1M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
−25
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
18 966
256
−366
−886
−1
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
18 966
256
−366
−886
−1
Net financials
−3 109
−1 114
871
1 696
319
Profit before tax
−612
−859
3 177
1 696
317
Tax
−0
452
−452
−1
−65
Net profit
−612
−407
2 725
1 695
252
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
108 264
23 670
24 022
25 682
26 000
Equity
21 668
21 262
23 987
25 682
25 935
Long-term debt
0
0
0
0
0
Short-term debt
83 990
1 952
35
0
65
Total debt
83 990
1 952
35
—
65
Financial ratios
5-year trend
EBITDA margin
-100000.0%
This company
15.8%
Market median
-633011% vs market
2021
2025
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
2021
2025
Return on equity
1.0%
This company
18.4%
Market median
-95% vs market
2021
2025
Net profit margin
25200000.0%
This company
8.1%
Market median
+311111011% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Recipharm Stockholm AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot